Testing effectiveness (Phase 2)Study completedNCT00895180
What this trial is testing
Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
Who this might be right for
Adult Glioblastoma Multiforme
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 80